Description
General introduction and principle of operation (Acivir Cream 5% Cipla)
Acivir Cream 5% Cipla is an effective topical antiviral medication specifically formulated to treat infections caused by the herpes simplex virus. By delivering the active ingredient acyclovir, this cream aids in reducing the severity and duration of genital and oral herpes outbreaks. It works by inhibiting viral DNA synthesis, thus preventing the virus from replicating and spreading further in the body. The application of Acivir Cream promotes faster healing of lesions and alleviates associated symptoms. Utilizing this medication as prescribed ensures optimal therapeutic outcomes for individuals suffering from herpes simplex infections.
Main components and active substances
The formulation of Acivir Cream contains several critical components that enhance its efficacy and stability. Understanding these ingredients can provide insight into how the product works and its essential role in the treatment process. The active substance, acyclovir, is a synthetic nucleoside analogue that is the cornerstone of the cream’s antiviral properties. In addition, there are several other excipients that support the delivery and absorption of the active ingredient. Here are the main components:
- Acyclovir: The primary active ingredient responsible for inhibiting viral replication.
- Water: Serves as the base for the cream, allowing for easy application.
- Cetyl alcohol: Functions as an emulsifier, maintaining the stability of the cream.
- Stearyl alcohol: Another emulsifier that enhances the texture and consistency of the product.
- Propylene glycol: Works as a humectant, providing moisture to the skin during application.
Mechanisms of action and expected results
The mechanisms of action of Acivir Cream are centered on its ability to disrupt the viral life cycle. By introducing acyclovir into the infected area, the cream inhibits the synthesis of viral DNA, which is crucial for virus replication. This action not only helps in controlling existing infections but also minimizes the likelihood of future outbreaks. Patients can typically expect a noticeable reduction in lesion size and duration of symptoms within a few days of consistent use. Here are some expected results:
- Reduction in pain and discomfort associated with herpes lesions.
- Faster healing time for sores and blisters.
- Lower frequency of outbreak recurrence when used at the onset of symptoms.
- Overall improvement in the quality of life for individuals affected by herpes.
Recommendations for use
To maximize the effectiveness of Acivir Cream, it is crucial to adhere to specific guidelines for application. The cream should be applied to the affected area as soon as the first signs of an outbreak are recognized. This proactive measure can significantly enhance the medication’s therapeutic effects. Here are recommendations for use:
- Apply a thin layer of the cream directly to the lesions five times a day for a period of five to ten days.
- Wash hands before and after application to prevent the spread of the virus.
- Avoid contact with the eyes and mucous membranes during application.
- Consult a healthcare professional if symptoms persist beyond the recommended treatment period.
Possible risks and contraindications (Acivir Cream 5% Cipla)
While Acivir Cream 5% Cipla is generally well tolerated, it is essential to be aware of possible risks and contraindications. Some individuals may experience adverse reactions or symptoms that warrant caution. Here are the potential risks:
- Local irritation: Some patients may experience itching, burning, or redness at the application site.
- Allergic reactions: Rarely, individuals may develop an allergic response to acyclovir or other ingredients.
- Not suitable for open wounds or severe skin reactions: Use is contraindicated in patients with broken skin, as this may exacerbate irritation.
- Consultation advised: Pregnant or nursing women should seek medical advice before use to ensure safety for both mother and child.
Additional information
| Active substance | Acyclovir |
|---|---|
| Water Retention | No significant effect |
| Hepatotoxicity | Rare |
| Lab Test | Not specific, may monitor renal function due to excretion pathways |
| Strength | 5% |
| Also known as | Aciclovir |
| Blood pressure | No significant effect |
| Trade name | Zovirax |
| Storage conditions | Store at room temperature between 15-25В°C (59-77В°F) |
| Chemical name | 9-[(2-Hydroxyethoxy)methyl]guanine |
| Formula | C8H11N5O3 |
| Substance class | Antiviral medication |
| Main action | Inhibits viral DNA synthesis |
| Half-life | 2.5 to 3.3 hours |
| Dosage (medical) | 400 mg orally three times a day for treatment of herpes simplex or as prescribed |
| Dosage (sports) | Not applicable |
| Effects | Reduces the duration and severity of herpes outbreaks |
| Side effects | Nausea, vomiting, diarrhea, headache, fatigue |
| Use in sports | Not typically used in sports |
| Manufacturer | Cipla Ltd. |
| Packing | 1 tube/pack |
Related products
-

Liver Support (Silymarin & Lecithin) Elbrus Pharmaceuticals
Select options This product has multiple variants. The options may be chosen on the product page -

Cortisol 300 mg Biaxol Supplements
Select options This product has multiple variants. The options may be chosen on the product page -

GDA (60 capsules) Biaxol Supplements
Select options This product has multiple variants. The options may be chosen on the product page




Reviews
There are no reviews yet.